VRTX — Vertex Pharmaceuticals Incorporated Share News
0.000.00%
Last trade - 00:00- $128.95bn
- $121.10bn
- $12.00bn
Crinetics soars after Vertex agrees to buy drugmaker in $10 billion deal
Brief: Vertex To Acquire Crinetics Pharmaceuticals In $10 Billion Deal
Vertex to buy Crinetics for $10 billion in rare-diseases push (updated)
Vertex to buy Crinetics in $10 billion deal
Brief: Vertex Signs LOI With pCPA For ALYFTREK In Cystic Fibrosis Treatment
US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two
Brief: Vertex Announces US FDA Acceptance Of Biologics License Application For Accelerated Approval Of Povetacicept In IgA Nephropathy
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings
Vertex Q1 adjusted EPS beats estimates, revenue rises 8%
Vertex tops profit estimates as sales of new cystic fibrosis drug surge
Brief: Vertex Pharmaceuticals Q1 Adjusted EPS USD 4.47 Vs. IBES Estimate USD 4.31
Halozyme rises as Vertex signs global drug delivery tech deal
Brief: Vertex Pharmaceuticals Inc - FDA Expands Indication For Trikafta In Cf Patients Ages 2 And Older
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies
Vertex rises after brokerage upgrade on kidney disease drug data
U.S. STOCKS ON THE MOVE-Rivian, Bunge, Vertex
Vertex rises on promising kidney-drug data
Street View: Vertex's kidney drug trial success boosts analysts' confidence